A Phase 2a study of OPK88004
Latest Information Update: 06 Jul 2017
Price :
$35 *
At a glance
- Drugs OPK 88004 (Primary)
- Indications Obesity; Type 2 diabetes mellitus
- Focus Therapeutic Use
- 06 Jul 2017 New trial record
Latest Information Update: 06 Jul 2017